Patents by Inventor Christopher B Glascock

Christopher B Glascock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
    Patent number: 7049406
    Abstract: The invention relates to novel recombinant hemoglobins having reduced nitric oxide scavenging and/or increased high soluble expression. The invention further relates to methods of increasing the soluble expression of recombinant hemoglobin by adding exogenous hemin in molar excess of the heme binding sites of recombinant hemoglobin.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: May 23, 2006
    Assignees: Baxter Biotech Technology SARL, William Marsh Rice University
    Inventors: Michael J Weickert, Christopher B Glascock, Antony J Mathews, Douglas D Lemon, Daniel H Doherty, John S Olson